1. Case of severe bullous erythema including intertrigo‐like eruptions with angioedema induced by pegylated liposomal doxorubicin
    Michiru Totsuka et al, 2019, The Journal of Dermatology CrossRef
  2. Liposome-Mediated Immunosuppression Plays an Instrumental Role in the Development of “Humanized Mouse” to Study Plasmodium falciparum
    Kunjal Agrawal et al, 2017, Liposomes CrossRef
  3. Oily core/amphiphilic polymer shell nanocapsules change the intracellular fate of doxorubicin in breast cancer cells
    Janaina Moreira Coelho et al, 2019, Journal of Materials Chemistry B CrossRef
  4. The Impact of Polymer Size and Cleavability on the Intravenous Pharmacokinetics of PEG-Based Hyperbranched Polymers in Rats
    Nirmal Marasini et al, 2020, Nanomaterials CrossRef
  5. On-chip combined radiotherapy and chemotherapy testing on soft-tissue sarcoma spheroids to study cell death using flow cytometry and clonogenic assay
    Bishnubrata Patra et al, 2019, Scientific Reports CrossRef
  6. Development and Characterization of Solid Lipid Nanoparticles Loaded with a Highly Active Doxorubicin Derivative
    Barbara Stella et al, 2018, Nanomaterials CrossRef
  7. Excessive skin toxicity in a patient receiving pegylated liposomal doxorubicin, associated with Nicolau syndrome, exacerbated by morbid obesity
    Petra Curescu et al, 2020, Oncolog-Hematolog.ro CrossRef
  8. Secrezione di sudore
    S. Rocour et al, 2023, EMC - Cosmetologia Medica e Medicina degli Inestetismi Cutanei CrossRef
  9. Diosmin alleviates doxorubicin-induced chemobrain in rats via inhibition of oxido-inflammation, apoptosis and modulation of autophagy
    Oyovwi O. Mega et al, 2024, Brain Disorders CrossRef
  10. Bioresorbable, Miniaturized Porous Silicon Needles on a Flexible Water-Soluble Backing for Unobtrusive, Sustained Delivery of Chemotherapy
    Hyungjun Kim et al, 2020, ACS Nano CrossRef
  11. Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system
    Akiho Fukuda et al, 2017, PLOS ONE CrossRef
  12. Doxorubicin–Loaded Human Serum Albumin Submicron Particles: Preparation, Characterization and In Vitro Cellular Uptake
    Saranya Chaiwaree et al, 2020, Pharmaceutics CrossRef
  13. Development, Characterization and Use of Liposomes as Amphipathic Transporters of Bioactive Compounds for Melanoma Treatment and Reduction of Skin Inflammation: A Review


    Erick Damian Castañeda-Reyes et al, 2020, International Journal of Nanomedicine CrossRef
  14. Drug eruptions associated with tumor therapy: Great imitators
    Catherine Ludwig et al, 2020, Clinics in Dermatology CrossRef
  15. Doxorubicin liposomal
    , 2016, Reactions Weekly CrossRef
  16. Pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia
    Kuan-Gen Huang et al, 2018, Gynecology and Minimally Invasive Therapy CrossRef
  17. Adrese efect of chemotherapy
    Veronika Novotná et al, 2020, Onkologie CrossRef
  18. In vivo detection of changes in cutaneous carotenoids after chemotherapy using shifted excitation resonance Raman difference and fluorescence spectroscopy
    Sora Jung et al, 2020, Skin Research and Technology CrossRef
  19. Surface active polyesters based on N-substituted glutamic acid as promising materials for biomedical applications
    Nataliia Fihurka et al, 2024, International Journal of Polymeric Materials and Polymeric Biomaterials CrossRef
  20. Decapeptide Modified Doxorubicin Loaded Solid Lipid Nanoparticles as Targeted Drug Delivery System against Prostate Cancer
    Kakali De, 2021, Langmuir CrossRef
  21. Recent advances in sialic acid-based active targeting chemoimmunotherapy promoting tumor shedding: a systematic review
    Jingyi Zhao et al, 2024, Nanoscale CrossRef
  22. Chemotherapeutic drugs induce oxidative stress associated with DNA repair and metabolism modulation
    Yujie Zhang et al, 2022, Life Sciences CrossRef